David Rosenkrantz

David A. Rosenkrantz was the founder of Patica Securities Ltd., founded in 2001, where the title held was President from 2010 to 2012.
Mr. Rosenkrantz is the founder of Patica Corp., founded in 1993, and holds the title of Chairman since 1993.
Current jobs include President, CEO, CFO & Director at Pinehurst Capital III, Inc. since 2020; Chairman at Aurora Spine Corp.
since 2013; Director at Neuromolecular, Inc. since 2001; and Chief Executive & Financial Officer, Director at Atlas One Capital Corp.
since 2022.
Former jobs include President, CEO, CFO & Director at Pinehurst Capital II, Inc.; Chairman at Versent Corp.; Chairman at Aralez Pharmaceuticals Canada, Inc.; Chairman at Carfinco Income Fund from 2002 to 2012; Chairman at Aimia, Inc. from 2021 to 2023; Chairman at Carfinco Financial Group, Inc. from 2013 to 2015; Chairman at Versent, Inc.; Chairman at Stellar Pharmaceuticals Inc; Director at Beta Brands, Inc.; Director at PreMD, Inc. from 1998 to 2008; Lead Director at Medisystem Technologies, Inc.; Independent Director at NexgenRx, Inc. from 2013 to 2019; Director at LymphoSign, Inc.; Director at Hamilton Tool Corp.
from 1999 to 2003; Director at Northern Mountain Helicopters Group, Inc. from 1996 to 2000; Director at RAS Completions Ltd.; Chief Executive & Financial Officer, Director at Pinehurst Capital I, Inc. from 2018 to 2021;.
Engineer at Stone & Webster, Inc.; Engineer at Shell Canada Ltd. Education includes an MBA from York University and an undergraduate degree from Carleton University conferred in 1979.